Results 31 to 40 of about 11,312 (211)

Der Einfluss biomechanischer Belastung auf die Entwicklung einer Enthesitis sowie optoakustisch basierte immunometabolische Profilierung der Enthesitis [PDF]

, 2023
1.1 Hintergrund und Ziele Die Psoriasis-Arthritis (PsA) ist eine chronisch-entzündliche Gelenkerkrankung mit einer Prävalenz von ungefähr 0,3-1%. Ein klinisches Merkmal der PsA ist die Enthesitis, die bei etwa 35 % der Patienten auftritt.
Simon, David
core   +1 more source

Burden of enthesitis on the quality of life and work productivity in psoriatic arthritis patients

Egyptian Rheumatology and Rehabilitation, 2022
Background Psoriatic arthritis (PsA) which affects 6–42% of psoriasis patients is the most common extra-cutaneous manifestation of the psoriasis disease.
Dalia S. Fahmi, Wafaa K. Makarm, Rabab S. Zaghlol   +2 more
doaj   +1 more source

Enthesitis in patients with psoriatic arthritis: A nationwide data from the Chinese Registry of Psoriatic Arthritis (CREPAR)

Chinese Medical Journal, 2023
. Background:. The clinical features of enthesitis in patients with psoriatic arthritis (PsA) have been reported in some Western countries, but data in China are very limited.
Fan Yang, Chaofan Lu, Huilan Liu, Lei Dou, Yanhong Wang, Hongbin Li, Xinwang Duan, Lijun Wu, Yongfu Wang, Xiuying Zhang, Jian Xu, Jinmei Su, Dong Xu, Jiuliang Zhao, Qingjun Wu, Mengtao Li, Xiaomei Leng, Xiaofeng Zeng, Lishao Guo   +18 more
doaj   +1 more source

Impact of Enthesitis on Psoriatic Arthritis Patient-Reported Outcomes and Physician Satisfaction with Treatment: Data from a Multinational Patient and Physician Survey

Rheumatology and Therapy, 2020
Introduction Enthesitis is a core outcome domain assessed in psoriatic arthritis (PsA) clinical trials. Limited evidence describes the impact of enthesitis on patient-reported outcomes (PROs) and physician satisfaction with current treatment options. The
Ana-Maria Orbai, Julie A. Birt, Elizabeth A. Holdsworth, Nicola Booth, William N. Malatestinic, Aubrey T. Sprabery, Anthony M. Reginato   +6 more
doaj   +1 more source

Comparison of Treatment Options for Enthesitis-Related Arthritis with the Juvenile Spondyloarthritis Disease Activity Index [PDF]

, 2023
Aim:The Juvenile Spondyloarthritis Disease Activity Index (JSpADA) is the only disease activity score specifically validated for children with enthesitis-associated arthritis (ERA).
Vafa Guliyeva, Nuray Aktay Ayaz, Fatma Gul Demirkan, Ozlem Akgun   +3 more
core   +1 more source

Assessment of enthesitis in patients with psoriasis: Relationships with clinical features, screening questionnaries results, and quality of life: An ultrasound study [PDF]

Vojnosanitetski Pregled, 2021
Background/Aim. Often asymptomatic, enthesitis can be an integral feature of the wide clinical spectrum in psoriasis as well as an early sign of development of psoriatic arthritis (PsA).
Dulović Dragan, Rančić Nemanja, Božić Ksenija, Stamatović Ratko, Mijušković Željko, Pešić Jasna, Kremić Zorana, Vojinović Radiša, Petronijević Milan   +8 more
doaj   +1 more source

Enthesitis is a clue to the diagnosis of spondyloarthritis, focus on psoriatic arthritis

Современная ревматология, 2021
Enthesitis is a common clinical feature of spondyloarthritis (SpA), characterized by inflammation of the tendon or ligament attachment site to a bone or joint capsule.
Ye. D. Yehudina, S. A. Trypolka
doaj   +1 more source

Enthesopathies and enthesitis. Part 1. Etiopathogenesis [PDF]

, 2015
The pathologies of tendon and ligament attachments are called enthesopathies. One of its types is enthesitis which is a characteristic sign of peripheral spondyloarthropathy.
Brygida Kwiatkowska, Sudoł-Szopińska, Iwona, Kwiatkowska, Brygida, Monika Prochorec-Sobieszek, Maśliński, Włodzimierz, Iwona Sudoł-Szopińska, Włodzimierz Maśliński, Prochorec-Sobieszek, Monika   +7 more
core   +1 more source

Impact of guselkumab, an interleukin-23 p19 subunit inhibitor, on enthesitis and dactylitis in patients with moderate to severe psoriatic arthritis: results from a randomised, placebo-controlled, phase II study

RMD Open, 2020
Objective To evaluate the effect of guselkumab on enthesitis and dactylitis in a phase II trial of patients with active psoriatic arthritis (PsA).Methods This was a phase II, randomised, placebo-controlled, double-blind trial of adults with active PsA ...
Peter Nash, Atul Deodhar, Philip J Mease, Dafna D Gladman, Philip S Helliwell, Dennis G McGonagle, Alice Gottlieb, Elizabeth C Hsia, Chetan S Karyekar, Wolf-Henning Boehncke, Xie L Xu, Stephen Xu   +11 more
doaj   +1 more source

Efficacy of tofacitinib on enthesitis in patients with active psoriatic arthritis: analysis of pooled data from two phase 3 studies

Arthritis Research & Therapy, 2023
Background Tofacitinib is an oral Janus kinase inhibitor for the treatment of psoriatic arthritis (PsA). This post hoc analysis assessed tofacitinib efficacy on enthesitis by baseline location and severity, and impact on disease activity and patient ...
Philip J. Mease, Ana-Maria Orbai, Oliver FitzGerald, Mohamed Bedaiwi, Dona L. Fleishaker, Rajiv Mundayat, Pamela Young, Philip S. Helliwell   +7 more
doaj   +1 more source